Epitalon
Also known as: Epithalon, AEDG peptide
Epitalon is a synthetic tetrapeptide studied for reported effects on telomerase activity and ageing. It is a research peptide that is not approved for human use, and its longevity claims are unproven in humans.
- Category
- Longevity / Anti-Aging
- Reported half-life
- Not well established
- Common forms
- Lyophilised powder for reconstitution, Research-grade solution
- Research status
- Studied in Russia and in laboratory models as a peptide bioregulator; not approved for human use in Australia. Longevity and anti-ageing claims are unproven in humans.
- Last updated
- 21 June 2026
Claimed effects
The following effects are reported or claimed by users and in early research. They are not established medical facts and many are not supported by large human trials.
- Reported in some studies to influence telomerase activity
- Studied for possible effects related to the pineal gland and melatonin rhythms
- Reported in animal research to be associated with longevity-related markers
- Reported to have antioxidant-related effects in laboratory models
How it is reported to work
Epitalon (often described as the sequence Ala-Glu-Asp-Gly) is a synthetic version of a peptide associated with the pineal gland. It is proposed to influence telomerase expression and circadian/melatonin regulation. These proposed mechanisms derive mainly from laboratory and animal studies, and the longevity claims associated with them are not established in humans.
Background
Epitalon is a synthetic short peptide associated with the pineal gland and studied as a so-called peptide bioregulator. It is most often discussed in the context of ageing and telomere biology. This page is educational information, not medical advice, and the effects below are reported claims, not established facts.
What the research shows
Epitalon research comes mainly from laboratory and animal studies, with some small studies from a limited number of groups. These suggest possible effects on telomerase and circadian markers, but the human longevity claims attached to Epitalon are not established and remain speculative.
| Evidence type | Status |
|---|---|
| Laboratory / animal studies | Present |
| Robust human longevity trials | Absent |
| Australian approval | None |
What people use it for (reported)
Online, people report interest in Epitalon for “anti-ageing” and sleep rhythm. These are anecdotal reports with no validated human outcomes. Reported benefits should not be read as proven, and nothing here is encouragement to use it.
Things to be aware of
Epitalon is not approved for human use in Australia, and its longevity claims are unproven in people. Long-term safety is unknown, and grey-market preparations cannot be verified for purity or identity. If you have health concerns, the appropriate step is to consult a qualified healthcare professional. This article does not recommend obtaining or using Epitalon.
Reported positives & side effects
Compiled from research and community reports. These are reported outcomes, not guarantees or medical advice, individual experiences vary widely.
Reported positives
- Reported by users to support a general sense of wellbeing and energy
- Reported in some studies to be associated with telomerase activity
- Reported to be linked with improved sleep and circadian rhythm via melatonin pathways
- Reported in animal research to be associated with longevity-related markers
- Reported to have antioxidant-related effects in laboratory models
Common side effects
- Reported injection-site redness or irritation with reconstituted research material
- Reported mild drowsiness or changes in sleep timing
- Reported transient headache
- Reported mild fatigue early in reported use
Rare / serious side effects
- Reported allergic or hypersensitivity reactions to unverified preparations
- Reported infection risk from non-sterile reconstitution and injection
- Unknown long-term effects, as no robust human safety data exists
Reported misuse & overdose risks
What has been reported to happen with overuse, excessive dosing, or long-term misuse of Epitalon. Listed so you can make an informed decision, not to suggest any use is safe.
- Reported self-injection of unregulated grey-market powder of unverified purity or identity
- Reported excessive dosing or prolonged continuous use based on unproven longevity claims
- Reported sharing or reusing of needles when self-administering research material
- Reported substitution of medical care with this unapproved peptide for serious conditions
Reported results timeline
Roughly how long people report it takes to notice effects. A general guide from reports, not a promise, and not advice. Users report subtle effects on sleep and wellbeing over weeks, with longevity claims unproven and not measurable by users.
First effects
Some report subtle sleep or mood changes within the first week
Noticeable change
Reported changes in energy and sleep quality over the first month
Clear results
Any reported wellbeing changes described over several months of cycles
Commonly reported dosing & protocol
Reported figures only, NOT a recommendation or dosing advice. These are numbers people report using, compiled for education so you can make an informed decision. We do not advise anyone to take Epitalon. Many peptides are not approved for human use in Australia. Speak to a qualified healthcare professional.
| Route | Subcutaneous (SubQ) injection |
|---|---|
| Typical reported dose | Reported at roughly 5–10 mg per day |
| Frequency | Reported once daily during a course |
| Cycle length | Reported in short courses of about 10–20 days, repeated a few times per year |
Reported reconstitution (mg → units)
Example only: a 50 mg vial reconstituted with 5 mL of bacteriostatic water gives 10 mg/mL. A 10 mg dose is about 1 mL (100 units on a U-100 syringe); a 5 mg dose is about 0.5 mL (50 units).
Work out the units for your vial → CalculatorReported use is commonly described as short cycles of daily dosing over 10-20 days, repeated a few times per year. This is reported information about patterns of use, not advice or a recommendation.
Best used with / commonly stacked with
Combinations people report using together. Reported, not recommended, stacking can increase risks.
Safety notes
Epitalon is not approved for human use in Australia, and its anti-ageing claims are unproven in humans. Long-term safety is not established, and grey-market preparations cannot be verified for purity or identity. Anyone with a health concern should consult a qualified healthcare professional rather than self-experiment.